Rubis SCA Share Price Euronext Paris
Stocks
RUBF
FR0000121253
Oil & Gas Refining and Marketing
OTC Markets Traded| Market Cap | 356.99Cr 399.72Cr 332.09Cr 302.07Cr 570.34Cr 39TCr 572.8Cr 4TCr 1.57TCr 20TCr 1.5TCr 1.47TCr 63TCr | P/E 2026 * |
10.2x | P/E 2027 * | 9.9x |
|---|---|---|---|---|---|
| Enterprise Value | 510.99Cr 572.15Cr 475.35Cr 432.37Cr 816.37Cr 55TCr 819.9Cr 5.72TCr 2.24TCr 28TCr 2.15TCr 2.1TCr 91TCr | EV / Sales 2026 * |
0.66x | EV / Sales 2027 * | 0.69x |
| Free-Float |
70.74% | Yield 2026 * |
6.27% | Yield 2027 * | 6.52% |
Last Transcript: Rubis SCA
| 1 day | +1.77% |
| Manager | Title | Age | Since |
|---|---|---|---|
Jacques Riou
PRN | Corporate Officer/Principal | - | 30/11/1992 |
Gilles Gobin
PRN | Corporate Officer/Principal | 76 | 30/06/1992 |
Marc Jacquot
DFI | Director of Finance/CFO | - | 07/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 45 | 05/06/2015 | |
| Chairman | 74 | 15/05/2025 | |
Carine Vinardi
BRD | Director/Board Member | - | 09/06/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.77% | +5.13% | - | - | 399.72Cr | |
| +2.00% | +4.88% | +53.24% | +61.55% | 69TCr | |
| -0.97% | -2.32% | -15.72% | -1.35% | 16TCr | |
| +1.41% | +6.26% | +151.15% | +212.09% | 13TCr | |
| +0.85% | +4.05% | +170.31% | +245.64% | 12TCr | |
| +0.29% | +4.40% | +39.34% | +9.68% | 12TCr | |
| +1.49% | +4.48% | +117.11% | +154.44% | 11TCr | |
| -0.66% | +2.85% | +9.88% | +7.01% | 9.18TCr | |
| +2.13% | +3.92% | +86.40% | +124.59% | 8.45TCr | |
| +0.58% | -2.01% | +44.12% | +114.47% | 5.96TCr | |
| Average | +0.89% | +3.78% | +72.87% | +103.12% | 17.53TCr | |
| Weighted average by Cap. | +1.15% | +3.63% | +65.63% | +86.58% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 776.29Cr 869.21Cr 722.15Cr 656.85Cr 1.24TCr 84TCr 1.25TCr 8.69TCr 3.41TCr 43TCr 3.26TCr 3.19TCr 1,37600Cr | 749.79Cr 839.54Cr 697.5Cr 634.43Cr 1.2TCr 81TCr 1.2TCr 8.39TCr 3.29TCr 41TCr 3.15TCr 3.08TCr 1,32900Cr |
| Net income | 35Cr 39Cr 32Cr 29Cr 56Cr 3.77TCr 56Cr 389.7Cr 152.69Cr 1.92TCr 146.35Cr 143.15Cr 6.17TCr | 36Cr 40Cr 33Cr 30Cr 57Cr 3.89TCr 58Cr 401.84Cr 157.45Cr 1.98TCr 150.91Cr 147.61Cr 6.36TCr |
| Net Debt | 154Cr 172.43Cr 143.26Cr 130.31Cr 246.03Cr 17TCr 247.1Cr 1.72TCr 675.57Cr 8.51TCr 647.52Cr 633.36Cr 27TCr | 159.7Cr 178.82Cr 148.56Cr 135.13Cr 255.14Cr 17TCr 256.24Cr 1.79TCr 700.59Cr 8.82TCr 671.49Cr 656.81Cr 28TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
